1. Home
  2. Nanobody‑based Pannexin1 channel inhibitors

Nanobody‑based Pannexin1 channel inhibitors

Nanobody‑based Pannexin1 channel inhibitors increase survival after cardiac ischemia/reperfusion

    Organizational unit
    KWAK-LAB
    Type
    Dataset
    DOI
    License
    Creative Commons Attribution 4.0 International
Publication date14/07/2025
Retention date12/07/2035
accessLevelPublicAccess levelPublic
SensitivityBlue
licenseContract on the use of data
License
Contributors
  • Kwak, Brenda orcid
34
0
  • Quality (0 Reviews)
  • Usefulness (0 Reviews)

Datacite metadata

Packages information

Similar archives

KWAK-LAB
Sex-dependent effects of Pannexin1 deletion in lymphatic endothelium
2023 accessLevelPublic Public 24.9 KB
KWAK-LAB
Pannexin1 in lymphatic endothelial cells in the progression of atherosclerosis
2024 accessLevelPublic Public 38.5 KB
All rights reserved by DLCM and the University of GenevaunigeBlack